Relevant bibliographies by topics / Antimycobacterial susceptibility

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters

Academic literature on the topic 'Antimycobacterial susceptibility'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antimycobacterial susceptibility.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antimycobacterial susceptibility"

1

Griffith, M. E., and H. L. Bodily. "Stability of antimycobacterial drugs in susceptibility testing." Antimicrobial Agents and Chemotherapy 36, no. 11 (1992): 2398–402. http://dx.doi.org/10.1128/aac.36.11.2398.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pitaloka, Dian Ayu Eka, and Elin Yulinah Sukandar. "IN VITRO STUDY OF URSOLIC ACID COMBINATION FIRST-LINE ANTITUBERCULOSIS DRUGS AGAINST DRUG-SENSITIVE AND DRUG-RESISTANT STRAINS OF Mycobacterium tuberculosis." Asian Journal of Pharmaceutical and Clinical Research 10, no. 4 (2017): 216. http://dx.doi.org/10.22159/ajpcr.2017.v10i4.16582.

Full text
Abstract:
Objective: The resurgence of tuberculosis (TB) caused by Mycobacterium TB (MTB) is associated with the rapid spread of multidrug-resistant,therefore, the development of new antimycobacterial agents is necessary. The aim of this study was to evaluate the antimycobacterial activity ofursolic acid (UA) when it using alone and combination with TB drugs.Methods: MTB H37Rv strain, streptomycin-rifampicin resistant strain, and isoniazid-ethambutol resistant strain were evaluated by susceptibility testusing a serial number of UA (25-150 µg/mL). Minimum inhibitory concentration (MIC) was read as minimu
APA, Harvard, Vancouver, ISO, and other styles
3

Sánchez, Juan Gabriel Bueno, and Vladimir V. Kouznetsov. "Antimycobacterial susceptibility testing methods for natural products research." Brazilian Journal of Microbiology 41, no. 2 (2010): 270–77. http://dx.doi.org/10.1590/s1517-83822010000200001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Inderlied, C. B. "Antimycobacterial susceptibility testing: Present practices and future trends." European Journal of Clinical Microbiology & Infectious Diseases 13, no. 11 (1994): 980–93. http://dx.doi.org/10.1007/bf02111499.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Portaels, F., H. Traore, K. De Ridder, and W. M. Meyers. "In Vitro Susceptibility of Mycobacterium ulcerans to Clarithromycin." Antimicrobial Agents and Chemotherapy 42, no. 8 (1998): 2070–73. http://dx.doi.org/10.1128/aac.42.8.2070.

Full text
Abstract:
ABSTRACT Buruli ulcer (BU), caused by Mycobacterium ulcerans, was recently recognized by the World Health Organization as an important emerging disease. While antimycobacterial therapy is often effective for the earliest nodular or ulcerative lesions, medical management of BU lesions in patients presenting for treatment is usually disappointing, leaving wide surgical excision the only alternative. Advanced ulcerated lesions of BU rarely respond to antimycobacterial agents; however, perioperative administration of such drugs may prevent relapses or disseminated infections. Clarithromycin posses
APA, Harvard, Vancouver, ISO, and other styles
6

Do, Thi Thuy, Jerónimo Rodríguez-Beltran, Esmeralda Cebrián-Sastre, Alexandro Rodríguez-Rojas, Alfredo Castañeda-García, and Jesús Blázquez. "Inactivation of a New Potassium Channel Increases Rifampicin Resistance and Induces Collateral Sensitivity to Hydrophilic Antibiotics in Mycobacterium smegmatis." Antibiotics 11, no. 4 (2022): 509. http://dx.doi.org/10.3390/antibiotics11040509.

Full text
Abstract:
Rifampicin is a critical first-line antibiotic for treating mycobacterial infections such as tuberculosis, one of the most serious infectious diseases worldwide. Rifampicin resistance in mycobacteria is mainly caused by mutations in the rpoB gene; however, some rifampicin-resistant strains showed no rpoB mutations. Therefore, alternative mechanisms must explain this resistance in mycobacteria. In this work, a library of 11,000 Mycobacterium smegmatis mc2 155 insertion mutants was explored to search and characterize new rifampicin-resistance determinants. A transposon insertion in the MSMEG_194
APA, Harvard, Vancouver, ISO, and other styles
7

K, Kalaiselvi, Mangayarkarasi V, Gomathi Ns, Balaji S, Shivshankar R. Mane, and Raja Shunmugam. "LUCIFERASE REPORTER MYCOBACTERIOPHAGES FOR EVALUATING NORBORNENE-BASED ANTITUBERCULOSIS DRUG SUSCEPTIBILITY TESTING ON MYCOBACTERIUM TUBERCULOSIS." Asian Journal of Pharmaceutical and Clinical Research 10, no. 9 (2017): 406. http://dx.doi.org/10.22159/ajpcr.2017.v10i9.19660.

Full text
Abstract:
Objective: In 2015, 9.6 million people around the world became sick with tuberculosis (TB) disease and 1.5 million TB-related deaths worldwide. Recent increasing incidence of multidrug-resistant (MDR; resistance to at least rifampicin (RIF) and isoniazid [INH]) and extensively drug-resistant (MDR resistance plus resistance to a fluoroquinolone and an aminoglycoside) makes TB a serious concern. Lot of research is needed to deal with this infectious disease for a better alternative in treatment or modification of these older TB drugs. The present study aimed at evaluating antimycobacterial activ
APA, Harvard, Vancouver, ISO, and other styles
8

Singh, Ashok K., Shailendra K. Singh, Kavita Dhariyal, Ram Kumar, Amarendra Kumar, and Sudheer K. Singh. "Synthesis, Characterization and Antimycobacterial Activity of Phenanthrenequinone Thiosemicarbazones and their Ruthenium and Zinc Complexes." Asian Journal of Chemistry 33, no. 5 (2021): 983–88. http://dx.doi.org/10.14233/ajchem.2021.23127.

Full text
Abstract:
The substituted phenanthrenequinone thiosemicarbazones (HL1, HL2 and HL3), and their metal complexes (M = Ru(II) or Zn(II); SM1, SM2, SM3 and SM4) were synthesized and characterized by FT-IR, 1H & 13C NMR and ESI-MS. The spectral data IR, 1H & 13C NMR and ESI-MS indicates two tridentate ligands coordinating in the form of an octahedral geometry. The gas phase geometry of all the zinc(II) and ruthenium(II) complexes was carried by using density functional theory (DFT). The antimycobacterial susceptibility testing at 100 μM of the complexes using resazurin microtiter plate assay resulted
APA, Harvard, Vancouver, ISO, and other styles
9

Obregón-Henao, Andrés, Kimberly A. Arnett, Marcela Henao-Tamayo, et al. "Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models." Antimicrobial Agents and Chemotherapy 59, no. 11 (2015): 6904–12. http://dx.doi.org/10.1128/aac.00459-15.

Full text
Abstract:
ABSTRACTOver the last 10 years,Mycobacterium abscessusgroup strains have emerged as important human pathogens, which are associated with significantly higher fatality rates than any other rapidly growing mycobacteria. These opportunistic pathogens are widespread in the environment and can cause a wide range of clinical diseases, including skin, soft tissue, central nervous system, and disseminated infections; by far, the most difficult to treat is the pulmonary form. Infections withM. abscessusare often multidrug-resistant (MDR) and require prolonged treatment with various regimens and, many t
APA, Harvard, Vancouver, ISO, and other styles
10

Lang, Markus, Uday S. Ganapathy, Rana Abdelaziz, Thomas Dick та Adrian Richter. "Broad-Spectrum In Vitro Activity of Nα-aroyl-N-aryl-Phenylalanine Amides against Non-Tuberculous Mycobacteria and Comparative Analysis of RNA Polymerases". Antibiotics 13, № 5 (2024): 404. http://dx.doi.org/10.3390/antibiotics13050404.

Full text
Abstract:
This study investigates the in vitro activity of Nα-aroyl-N-aryl-phenylalanine amides (AAPs), previously identified as antimycobacterial RNA polymerase (RNAP) inhibitors, against a panel of 25 non-tuberculous mycobacteria (NTM). The compounds, including the hit compound MMV688845, were selected based on their structural diversity and previously described activity against mycobacteria. Bacterial strains, including the M. abscessus complex, M. avium complex, and other clinically relevant NTM, were cultured and subjected to growth inhibition assays. The results demonstrate significant activity ag
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Antimycobacterial susceptibility"

1

DeCoster, David J. "Comparison of the BACTEC TB-460 system, flow cytometric susceptibility assay and proportion method for susceptibility of mycobacterium tuberculosis to antimycobacterial agents." 2004. http://catalog.hathitrust.org/api/volumes/oclc/56190530.html.

Full text
Abstract:
Thesis (M.S.)--University of Wisconsin--Madison, 2004.<br>Typescript. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves 20-25).
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Antimycobacterial susceptibility"

1

Antimycobacterial Susceptibility Testing Proposed Standard (Nccls Document M24-P). NCCLC, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Antimycobacterial susceptibility"

1

Philley, Julie V., and David E. Griffith. "Antimycobacterial Consideration in Transplantation Including Drug Non-susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease." In Principles and Practice of Transplant Infectious Diseases. Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9034-4_56.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Antimycobacterial susceptibility' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography